Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20203
20213
20222
20233
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Active, not recruiting3
Completed1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Aminex Therapeutics, Inc.1
Avenzo Therapeutics, Inc.1
BioNTech SE1
Daiichi Sankyo1
DualityBio Inc.1
Eikon Therapeutics1
Eli Lilly and Company1
GlaxoSmithKline1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms20
Colorectal Neoplasms13
Ovarian Neoplasms13
Carcinoma, Non-Small-Cell Lung9
Neoplasm Metastasis8
Breast Neoplasms7
Stomach Neoplasms7
Melanoma6
Biliary Tract Neoplasms5
Neoplasms5

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.